Provided by Tiger Trade Technology Pte. Ltd.

Genprex, Inc.

2.20
0.0000
Post-market: 2.230.0254+1.15%19:44 EST
Volume:217.06K
Turnover:476.19K
Market Cap:5.10M
PE:-0.06
High:2.29
Open:2.24
Low:2.11
Close:2.20
52wk High:55.00
52wk Low:1.71
Shares:2.32M
Float Shares:2.27M
Volume Ratio:0.43
T/O Rate:9.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-37.3218
EPS(LYR):-266.9534
ROE:-1401.39%
ROA:-273.31%
PB:6.64
PE(LYR):-0.01

Loading ...

Genprex Faces Nasdaq Delisting Risk if Equity Compliance Lapses Within Monitoring Period

Reuters
·
Jan 10

Congressman Who Was Top 2025 Stock Picker Buys Shares Of $5M Company You've Never Heard Of

Benzinga_recent_news
·
Jan 10

Genprex Reports Positive Preclinical Results for Diabetes Gene Therapy Candidate

Reuters
·
Jan 07

Genprex Provides Clinical Update on Diabetes Gene Therapy Program

THOMSON REUTERS
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

Reuters
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Reuters
·
Jan 06

BUZZ-Genprex rises as diabetes gene therapy shows promise in animal tests

Reuters
·
Jan 06

Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Gene Therapy

Reuters
·
Jan 06

Genprex Announces Positive Preliminary Preclinical Data From Study of Gpx-002 in Type 2 Diabetic Animal Studies

THOMSON REUTERS
·
Jan 06

Genprex Faces Nasdaq Listing Uncertainty Over Stockholders' Equity Compliance

Reuters
·
Dec 23, 2025

Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of

Benzinga_recent_news
·
Dec 05, 2025

Genprex Faces Nasdaq Delisting Risk Over Compliance Shortfalls

Reuters
·
Nov 26, 2025

Data From Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer

THOMSON REUTERS
·
Nov 24, 2025

Genprex files to sell 1.28M shares of common stock for holders

TIPRANKS
·
Nov 22, 2025

Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials

THOMSON REUTERS
·
Nov 19, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Energizer Holdings, Target

Reuters
·
Nov 19, 2025

Genprex Shares up 2% After Co Receives U.S. Patent for Its Cancer Combo Drug

THOMSON REUTERS
·
Nov 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Cloudflare, Legence, Lumentum

Reuters
·
Nov 18, 2025

Genprex Granted U.S. Patent for Reqorsa® Gene Therapy Combined with PD-L1 Antibodies to Treat Cancer

Reuters
·
Nov 18, 2025

Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination With Pd-L1 Antibodies to Treat Cancers

THOMSON REUTERS
·
Nov 18, 2025